comparemela.com

Page 14 - Masimo Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Masimo Co to Post Q1 2023 Earnings of $0 83 Per Share, Zacks Research Forecasts (NASDAQ:MASI)

Masimo Co. (NASDAQ:MASI – Get Rating) – Equities research analysts at Zacks Research decreased their Q1 2023 earnings per share (EPS) estimates for shares of Masimo in a note issued to investors on Wednesday, April 26th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical equipment provider will post earnings per share of $0.83 […]

Brokerages Set Masimo Co (NASDAQ:MASI) Target Price at $182 00

Masimo Co. (NASDAQ:MASI – Get Rating) has earned an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among […]

Masimo Co (NASDAQ:MASI) Receives $182 00 Consensus PT from Brokerages

Shares of Masimo Co. (NASDAQ:MASI – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price […]

Masimo Co (NASDAQ:MASI) Short Interest Down 17 9% in March

Masimo Co. (NASDAQ:MASI – Get Rating) saw a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 734,200 shares, a decrease of 17.9% from the March 15th total of 894,000 shares. Currently, 1.5% of the company’s stock are short sold. Based on an average daily […]

Masimo Co (NASDAQ:MASI) Receives Consensus Recommendation of Moderate Buy from Analysts

Masimo Co. (NASDAQ:MASI – Get Rating) has received a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.